Compass Therapeutics, Inc.: Form 8-K, filed Nov 3, 2021
Filed with the SEC on Nov 3, 2021 and accepted by EDGAR at Nov 3, 2021, 21:29 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 8.01 Other events
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000950170-21-002863. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.